Survival based on income for intrahepatic, perihilar, and distal tumors
| Intrahepatic | Perihilar | Distal | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Overall | Low income | High income | Overall | Low income | High income | Overall | Low income | High income | ||||||
| Number | 2,082 | 486 | 1,596 | 1,424 | 371 | 1,053 | 490 | 141 | 349 | |||||
| Overall mortality | 1,844 (88.6) | 448 (92.2) | 1,396 (87.5) | 0.005 | 1,311 (92.1) | 348 (93.8) | 963 (91.5) | 0.185 | 404 (82.4) | 123 (87.2) | 281 (80.5) | 0.101 | ||
| 2-year mortality | 1,674 (80.4) | 421 (86.6) | 1,253 (78.5) | < 0.001 | 1,162 (81.6) | 308 (83.0) | 854 (81.1) | 0.458 | 365 (74.5) | 117 (83.0) | 248 (71.1) | 0.009 | ||
| 5-year mortality | 1,823 (87.6) | 446 (91.8) | 1,377 (86.3) | 0.002 | 1,276 (89.6) | 339 (91.4) | 937 (89.0) | 0.231 | 402 (82.0) | 123 (87.2) | 279 (79.9) | 0.076 | ||
| Overall cancer-specific mortality | 1,737 (83.4) | 427 (87.9) | 1,310 (82.1) | 0.003 | 1,190 (83.6) | 315 (84.9) | 875 (83.1) | 0.467 | 348 (71.0) | 102 (72.3) | 246 (70.5) | 0.765 | ||
| 2-year cancer-specific mortality | 1,580 (75.9) | 400 (82.3) | 1,180 (73.9) | < 0.001 | 1,077 (75.6) | 286 (77.1) | 791 (75.1) | 0.49 | 314 (64.1) | 97 (68.8) | 217 (62.2) | 0.201 | ||
| 5-year cancer-specific mortality | 1,717 (82.5) | 425 (87.4) | 1,292 (81.0) | 0.001 | 1,176 (82.6) | 312 (84.1) | 864 (82.1) | 0.416 | 346 (70.6) | 102 (72.3) | 244 (69.9) | 0.671 | ||
| Overall non-cancer mortality | 107 (5.1) | 21 (4.3) | 86 (5.4) | 0.415 | 121 (8.5) | 33 (8.9) | 88 (8.4) | 0.833 | 56 (11.4) | 21 (14.9) | 35 (10.0) | 0.169 | ||
| 2-year non-cancer mortality | 94 (4.5) | 21 (4.3) | 73 (4.6) | 0.912 | 85 (6.0) | 22 (5.9) | 63 (6.0) | > 0.999 | 51 (10.4) | 20 (14.2) | 31 (8.9) | 0.115 | ||
| 5-year non-cancer mortality | 106 (5.1) | 21 (4.3) | 85 (5.3) | 0.445 | 100 (7.0) | 27 (7.3) | 73 (6.9) | 0.916 | 56 (11.4) | 21 (14.9) | 35 (10.0) | 0.169 | ||
Values are presented as number only or number (%).